Properties		Conclusion a
CMR	Carcinogenicity (C)	Metalaxyl‐M is not considered to be a carcinogen according to point 3.6.3 of Annex II of Regulation (EC) No 1107/2009
	Mutagenicity (M)	Metalaxyl‐M is not considered to be a mutagen according to point 3.6.2 of Annex II of Regulation (EC) No 1107/2009
	Toxic for Reproduction (R)	Metalaxyl‐M is not considered to be a reproductive toxicant according to point 3.6.4 of Annex II of Regulation (EC) No 1107/2009
Endocrine disrupting properties		The endocrine disruption properties of metalaxyl‐M according to points 3.6.5 and 3.8.2 of Annex II of Regulation No 1107/2009, as amended by Commission Regulation (EU) 2018/605 were not discussed in this conclusion
POP	Persistence	Metalaxyl‐M is not considered to be a persistent organic pollutant (POP) according to point 3.7.1 of Annex II of Regulation (EC) 1107/2009
	Bioaccumulation
	Long‐range transport
PBT	Persistence	Metalaxyl‐M not considered to be a persistent, bioaccumulative and toxic (PBT) substance according to point 3.7.2 of Annex II of Regulation (EC) 1107/2009
	Bioaccumulation
	Toxicity
vPvB	Persistence	Metalaxyl‐M not considered to be a very persistent, very bioaccumulative substance according to point 3.7.3 of Annex II of Regulation (EC) 1107/2009
	Bioaccumulation

^a Origin of data to be included where applicable (e.g. EFSA, ECHA RAC, Regulation).